Cargando…

Modulation of Protein–Protein Interactions for the Development of Novel Therapeutics

Protein–protein interactions (PPIs) underlie most biological processes. An increasing interest to investigate the unexplored potential of PPIs in drug discovery is driven by the need to find novel therapeutic targets for a whole range of diseases with a high unmet medical need. To date, PPI inhibiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petta, Ioanna, Lievens, Sam, Libert, Claude, Tavernier, Jan, De Bosscher, Karolien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886928/ https://www.ncbi.nlm.nih.gov/pubmed/26675501 http://dx.doi.org/10.1038/mt.2015.214

Ejemplares similares

Glucocorticoid Receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor
por: Petta, Ioanna, et al.
Publicado: (2017)

The nature of the GRE influences the screening for GR-activity enhancing modulators
por: Dendoncker, Karen, et al.
Publicado: (2017)

Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα
por: Ratman, Dariusz, et al.
Publicado: (2016)

The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages
por: Mylka, Viacheslav, et al.
Publicado: (2018)

Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1
por: De Bosscher, Karolien, et al.
Publicado: (2013)

Mechanisms Underlying the Functional Cooperation Between PPARα and GRα to Attenuate Inflammatory Responses
por: Bougarne, Nadia, et al.
Publicado: (2019)

Compound A, a Selective Glucocorticoid Receptor Modulator, Enhances Heat Shock Protein Hsp70 Gene Promoter Activation
por: Beck, Ilse M., et al.
Publicado: (2013)

ZBTB32 performs crosstalk with the glucocorticoid receptor and is crucial in glucocorticoid responses to starvation
por: Van Wyngene, Lise, et al.
Publicado: (2021)

A screening assay for Selective Dimerizing Glucocorticoid Receptor Agonists and Modulators (SEDIGRAM) that are effective against acute inflammation
por: Souffriau, Jolien, et al.
Publicado: (2018)

The Zinc-Finger Domain Containing Protein ZC4H2 Interacts with TRPV4, Enhancing Channel Activity and Turnover at the Plasma Membrane
por: Vangeel, Laura, et al.
Publicado: (2020)

MAPPI-DAT: data management and analysis for protein–protein interaction data from the high-throughput MAPPIT cell microarray platform
por: Gupta, Surya, et al.
Publicado: (2017)

Straightforward Protein-Protein Interaction Interface Mapping via Random Mutagenesis and Mammalian Protein Protein Interaction Trap (MAPPIT)
por: Vyncke, Laurens, et al.
Publicado: (2019)

Turning a pathogen protein into a therapeutic tool for sepsis
por: Vanderhaeghen, Tineke, et al.
Publicado: (2020)

Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2018)

An acute phase protein ready to go therapeutic for sepsis
por: Vandevyver, Sofie, et al.
Publicado: (2014)

How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
por: Clarisse, Dorien, et al.
Publicado: (2021)

The Biologist’s Guide to the Glucocorticoid Receptor’s Structure
por: Deploey, Nick, et al.
Publicado: (2023)

Delayed development of the protective IL-17A response following a Giardia muris infection in neonatal mice
por: Paerewijck, Oonagh, et al.
Publicado: (2019)

TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity
por: Mori, Raffaele, et al.
Publicado: (2017)

Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2017)

Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?
por: Van Moortel, Laura, et al.
Publicado: (2020)

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
por: Lu, Haiying, et al.
Publicado: (2020)

Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
por: Van Wyngene, Lise, et al.
Publicado: (2018)

RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes
por: Masschaele, Delphine, et al.
Publicado: (2017)

Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions
por: Ershov, Pavel V., et al.
Publicado: (2022)

Differential Cytokine Profiles upon Comparing Selective versus Classic Glucocorticoid Receptor Modulation in Human Peripheral Blood Mononuclear Cells and Inferior Turbinate Tissue
por: Beck, Ilse M., et al.
Publicado: (2015)

Trapping mammalian protein complexes in viral particles
por: Eyckerman, Sven, et al.
Publicado: (2016)

Modulating Protein–Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples
por: González-Muñiz, Rosario, et al.
Publicado: (2021)

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021)

RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding
por: Wauman, Joris, et al.
Publicado: (2011)

Recent developments in therapeutic protein expression technologies in plants
por: Fahad, Shah, et al.
Publicado: (2014)

Modulators of protein–protein interactions as antimicrobial agents
por: Kahan, Rashi, et al.
Publicado: (2021)

Small Molecule Targeting of Protein–Protein Interactions through Allosteric Modulation of Dynamics
por: Cossins, Benjamin P., et al.
Publicado: (2015)

A novel functional module detection algorithm for protein-protein interaction networks
por: Hwang, Woochang, et al.
Publicado: (2006)

Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease
por: Silvestro, Serena, et al.
Publicado: (2023)

A Mediator Role For Metallothionein in Tumor Necrosis Factor–induced Lethal Shock
por: Waelput, Wim, et al.
Publicado: (2001)

Computational developments in microRNA-regulated protein-protein interactions
por: Zhu, Wei, et al.
Publicado: (2014)

Recent developments of sequence-based prediction of protein–protein interactions
por: Murakami, Yoichi, et al.
Publicado: (2022)

Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
por: Wondafrash, Dawit Zewdu, et al.
Publicado: (2020)

Recent advances in (therapeutic protein) drug development
por: Lagassé, H.A. Daniel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nt6hjkcchq39vuip93h85ui8v6